PUBLISHED DATE : Oct 2022 | Pages : 177
Fill out your details & get your free sample
The U.S. Sleep Disorder Clinics Market Report Size, Share, Growth Forecast analysis by
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022-2027
177 Pages
32 Tables
84 Charts
4 Regions
1 Countries
31 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 5.55 Billion |
| Market Size (2021) | USD 7.44 Billion |
| CAGR (2021-2027) | 5.01% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Ownership, Applications, Payor, and Region |
| Geographic Analysis | U.S. (East, South, West, Midwest) |
The U.S. sleep disorder clinics market was valued at USD 5.55 billion in 2021 and is expected to reach USD 7.44 billion by 2027, growing at a CAGR of 5.01% from 2022 to 2027. One in three Americans reports insufficient sleep every night. Sleep disorders remain underdiagnosed, and some people experience restless nights. A few nights of toss and turns can be due to stress or changes in daily life, but the inability to fall asleep or sleep for long periods indicates a need to visit a sleep clinic. Problems such as falling and staying asleep, snoring, choking, and gasping during sleep can be painful. Understanding what a sleep clinic is and what happens there can help with diagnosis and treatment. These elements have contributed to the expansion of the U.S. sleep disorder clinics market and the growth of the sleep market.
Sleep center and sleep clinic are terms that are used interchangeably. Both terms refer to the medical field where sleep tests are performed. Some sleep laboratories are dedicated to testing, while others provide testing along with outpatient treatment for people with insomnia. Sleep clinics can help people diagnose sleep disorders and sleep problems. The sleep clinic can diagnose common sleep disorders such as obstructive sleep apnea, insomnia, and narcolepsy.
The Sleep lab services are of three distinct types: sleep facility, sleep clinic, and sleep labs. The sleep facility contains a clinic for evaluating patients and a laboratory for diagnosing patients. A sleep clinic is an outpatient facility where patients can visit, get diagnosed, and receive treatment for their sleep conditions. Sleep labs, on the other hand, are where the diagnosis of sleep disorder is performed. It can be in-lab testing or house sleep testing.
On the other hand, home sleep testing is only helpful in diagnosing sleep apnea testing. HST is only prescribed when the physician ensures that the patient suffers from obstructive sleep apnea. It is not recommended for other sleep disorders. Along with the analysis of night sleep, sleep lab services also perform day sleep studies. Technologies such as actigraphy, multiple sleep latency tests, PAP therapy, and home sleep studies are used for day sleep studies. Actigraphy involves using a wearable sleep monitor to address a person's sleep pattern. Multiple Sleep Latency Test addresses sleep patterns after an overnight sleep study. PAP therapy is used to train the patient to use the PAP machine for sleep apnea management and to make them comfortable with its use.
With the increasing prevalence of sleep disorders, the requirement for sleep labs is also rising. Accurate diagnosis is essential for the determination of sleeping disorders. Because of higher medical accuracy, polysomnography is the most preferred technology for diagnosis. With the increasing incidences of sleeping disorders, the demand for sleep facilities and clinics equipped with technologically advanced PSGs.
Shift Towards The Home-Based Care Model
The sleep apnea studies have been shifting to the home for many years. And the trend has only enhanced during the pandemic. According to EnsoData's survey, pre-COVID volumes were 70% in-lab and 30% home sleep testing (HST), which found this in-lab to home testing ratio flipped during the pandemic. The significant reduction in sleep center activity due to COVID-19 has most definitely accelerated the adoption of online consultations, remote patient care, and starting and dispatch of home sleep apnea testing (HSAT) technologies utilizing home delivery by the sleep centers.
Cloud-Based Diagnostic Platforms for Sleep Disorder Professionals
Cloud computing offers sleep professionals access to real-time patient data from anywhere with access to the internet. From CPAP compliance to managing continuity of care, these software solutions are ready to simplify the lives of providers and patients. A growing number of CPAP and clinic management software providers are switching to cloud-based systems to make sleep medicine practices more efficient and successful. The primary goals of ubiquitous computing in sleep tracking are sensor miniaturization and non-invasive sensing that can comprehensively monitor the physiological signals associated with sleep activity.
Growing Prevalence of Sleep Disorders
The prevalence of sleep disorders differs widely depending on the individual study and disorder. However, the majority of sleep disorders among the population is 20-40%. The prevalence of sleep disorders in the US follows a similar pattern, affecting 50 to 70 million adults in the US. According to sleep deprivation statistics, about 35% of adults in the US report less than 7 hours of sleep in the normal 24 hours.
Sleep deprivation data show that men and women are equally affected. Recent studies of US veterans highlight the prevalence of sleep disorders. A survey conducted in 2021 by the Journal of Clinical Sleep Medicine reported that undiagnosed, poorly treated sleep disorders are common in veterans at risk for cardiovascular disease. In a sample of 420 veterans, more than half (52.1%) were positive for sleep apnea. In addition to the high prevalence of sleep apnea, many veterans also experience insomnia.
Increasing Awareness of Sleep Disorders
The AAHS aims to promote healthy sleep and improve the lives of people with sleep disorders. Membership connects patients and health care providers in a partnership to enhance sleep health for all. The American Alliance for Healthy Sleep collaborates with patients, providers, and others interested in promoting healthy sleep. These promotional activities target the population and medical specialists. Such as pulmonologists, sleep medicine specialists, primary care physicians, cardiologists, neurologists, and other medical subspecialists treating these conditions and their associated comorbidities.
A nationwide shortage of medical specialists coupled with a tech-savvy patient population is an opportunity for advances in health care access. Because sleep medicine is not a procedure-based specialty, this field holds special promise for telehealth-based approaches.
Sleep telehealth has already been evaluated in several settings and has promise for remote care. For sleep-disordered breathing, computer-based cognitive behavioral therapy for insomnia (CBT-I), home sleep testing, actigraphy, commercial wearables, and modem-enabled continuous positive airway pressure devices provide a robust platform for effective sleep telehealth. Given the advancing digital technologies, remote sleep technologies will move faster than earlier innovations in medical care that have impacted training programs. Today, the consumer obsession with self-monitoring activities such as fitness trackers and sleep is fostering innovation at an exponentially faster pace, with personal proprietary data for which patients look to their health providers for validation.
NEWLY DISCOVERED SLEEP TESTING BEST PRACTICES
The geographic distribution of sleep disorders in the U.S. is uneven. Some areas experience disproportionately high amounts of insufficient sleep, which has become an essential public health issue. On the basics of the region, the U.S. sleep disorder clinics market segments into East, West, South, and Midwest. The East region accounts for a significant stake in 2021.
The states in the East have the highest prevalence of sleep disorders as the people there suffer from limited sleeping hours. The sleep disorder clinics market in this region gets a boost by factors like prolonged usage of digital gadgets like mobile phones, a high number of advanced streetlights, and an increase in light pollution, which increases the use of lights at night.
The U.S. sleep disorder clinics market witnesses a moderate threat of new entrants. The country reports a significant number of clinics in the market and an increasing prevalence of sleep disorders, raising the demand for diagnosis and treatment. Though there is high demand for sleep diagnosis services, there is less competition among the players in the market. The clinics in the market face competition from a range of other companies that specialize in delivering services that offer easy access to sleep disorder management.
Few players in the market like SleepMed, SleepWorks, and Comprehensive Sleep Care have a chain of labs and perform a large volume of sleep studies. Many hospitals affiliated clinics and large multispecialty hospitals have sleep labs as a part of their consultation. There is a massive increase in patients suffering from sleep disorders, pressuring hospitals to develop more sleep study centers. The key companies are investing mainly in mergers and acquisitions. One of the significant acquisitions is that SleepMed acquired one of the US's largest home sleep study providers.
Frequently Asked Questions
What is the growth rate of the U.S. sleep disorder clinics market?
The U.S. sleep disorder clinics market is expected to grow at a CAGR of 5.01% from 2022-2027.
What is the estimated U.S. sleep disorder clinics market share by 2027?
The U.S. sleep disorder clinics market share is estimated to reach USD 7.44 billion by 2027.
Who are the leading players in the U.S. sleep disorder clinics market?
Comprehensive Sleep Care, SleepMed, and SleepWorks are the key players in the U.S. sleep disorder clinics market.
What are the factors driving the U.S. sleep disorder clinics market?
The growing prevalence of sleep disorders and increasing awareness of sleep disorders are some prime factors driving the U.S. sleep disorder clinics market.
Which region in the U.S. is leading the U.S. sleep disorder clinics market?
The East region dominates the U.S. sleep disorder clinics market.
The U.S. sleep disorder clinics market is expected to grow at a CAGR of approximately 5.01% during 2022-2027.
The following factors are likely to contribute to the growth of the U.S. sleep disorder clinics market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the U.S. sleep disorder clinics market and its market dynamics for the period 2022−2076. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Segmentation by Ownership
Segmentation by Applications
Segmentation by Payor
Segmentation by Region
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 OWNERSHIP SEGMENTATION
4.3.2 APPLICATIONS SEGMENTATION
4.3.3 PAYOR SEGMENTATION
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
8 INTRODUCTION
8.1 OVERVIEW
8.2 ROLE OF TELEMEDICINE IN MITIGATING SLEEP DISORDERS
8.2.1 TELEMEDICINE ADOPTION AMONG US PHYSICIANS
9 MARKET OPPORTUNITIES & TRENDS
9.1 USE OF ADVANCED TECHNOLOGIES TO ADDRESS SLEEP-LOSS EPIDEMIC
9.2 SHIFT TOWARD HOME-BASED CARE MODEL
9.3 ADOPTION OF CLOUD-BASED SOLUTIONS FOR SLEEP DISORDER MANAGEMENT
10 MARKET GROWTH ENABLERS
10.1 SURGE IN PREVALENCE OF SLEEP DISORDERS
10.2 ECONOMIC BURDEN OF SLEEP DISORDERS
10.3 RISE IN AWARENESS OF SLEEP DISORDERS
11 MARKET RESTRAINTS
11.1 SHORTAGE OF PEDIATRIC SLEEP LABORATORIES
11.2 COVID-19 & IMPLICATIONS ON SLEEP MEDICINE
11.3 FRAUDULENT BILLING PRACTICES BY SLEEP STUDY CLINICS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 OWNERSHIP INSIGHTS
12.2.2 APPLICATIONS INSIGHTS
12.2.3 PAYOR INSIGHTS
12.2.4 REGION INSIGHTS
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 THREAT OF RIVALRY
13 OWNERSHIP
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 AFFILIATED CLINICS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.4 INDEPENDENT CLINICS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 SLEEP TESTING
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.4 PAP THERAPY
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.5 CONSULTATION
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.6 OTHERS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
15 PAYOR
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 PRIVATE HEALTH INSURANCE
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.4 PUBLIC HEALTH INSURANCE
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.5 OUT-OF-POCKET
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
16 REGION
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 EAST
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.4 SOUTH
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.5 WEST
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.6 MIDWEST
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
17 COMPETITIVE LANDSCAPE
17.1 COMPETITION OVERVIEW
17.2 MARKET SHARE ANALYSIS
17.2.1 COMPREHENSIVE SLEEP CARE
17.2.2 SLEEPMED
17.2.3 SLEEPWORKS
18 KEY COMPANY PROFILES
18.1 COMPREHENSIVE SLEEP CARE
18.1.1 BUSINESS OVERVIEW
18.1.2 KEY STRATEGIES
18.1.3 KEY STRENGTHS
18.1.4 KEY OPPORTUNITIES
18.2 SLEEPMED
18.2.1 BUSINESS OVERVIEW
18.2.2 KEY STRATEGIES
18.2.3 KEY STRENGTHS
18.2.4 KEY OPPORTUNITIES
18.3 SLEEPWORKS
18.3.1 BUSINESS OVERVIEW
18.3.2 KEY STRATEGIES
18.3.3 KEY STRENGTHS
18.3.4 KEY OPPORTUNITIES
19 OTHER PROMINENT VENDORS
19.1 ADVANTAGE SLEEP CENTERS
19.1.1 BUSINESS OVERVIEW
19.2 ANCHORAGE SLEEP CENTER
19.2.1 BUSINESS OVERVIEW
19.3 AU HEALTH
19.3.1 BUSINESS OVERVIEW
19.4 BUTLER HEALTH SYSTEM
19.4.1 BUSINESS OVERVIEW
19.5 CLARK MEMORIAL HEALTH
19.5.1 BUSINESS OVERVIEW
19.6 CLAYTON SLEEP INSTITUTE
19.6.1 BUSINESS OVERVIEW
19.7 CLEVELAND CLINIC
19.7.1 BUSINESS OVERVIEW
19.8 ENGLEWOOD HEALTH
19.8.1 BUSINESS OVERVIEW
19.9 GRAND VIEW HEALTH
19.9.1 BUSINESS OVERVIEW
19.10 HUNTERDON HEALTH
19.10.1 BUSINESS OVERVIEW
19.11 INTERMOUNTAIN HEALTHCARE
19.11.1 BUSINESS OVERVIEW
19.12 JUPITER MEDICAL CENTER
19.12.1 BUSINESS OVERVIEW
19.13 KOALA CENTER FOR SLEEP & TMJ DISORDERS
19.13.1 BUSINESS OVERVIEW
19.14 MAYO CLINIC
19.14.1 BUSINESS OVERVIEW
19.15 NATIONWIDE CHILDREN’S HOSPITAL
19.15.1 BUSINESS OVERVIEW
19.16 PENN MEDICINE
19.16.1 BUSINESS OVERVIEW
19.17 SLEEP CENTER OF NEVADA
19.17.1 BUSINESS OVERVIEW
19.18 SLEEP MEDICINE ASSOCIATES OF TEXAS
19.18.1 BUSINESS OVERVIEW
19.19 SOMERSET PULMONARY AND SLEEP MEDICINE CENTER
19.19.1 BUSINESS OVERVIEW
19.20 STANFORD HEALTH CARE
19.20.1 BUSINESS OVERVIEW
19.21 CENTER FOR SLEEP MEDICINE
19.21.1 BUSINESS OVERVIEW
19.22 THOMAS JEFFERSON UNIVERSITY HOSPITALS
19.22.1 BUSINESS OVERVIEW
19.23 UAB HEALTH SYSTEM
19.23.1 BUSINESS OVERVIEW
19.24 UCLA HEALTH
19.24.1 BUSINESS OVERVIEW
19.25 UNIVERSITY OF ILLINOIS HOSPITAL & HEALTH SCIENCES SYSTEM
19.25.1 BUSINESS OVERVIEW
19.26 USA SLEEP DIAGNOSTIC SERVICES
19.26.1 BUSINESS OVERVIEW
19.27 VALLEY HEALTH SYSTEM
19.27.1 BUSINESS OVERVIEW
19.28 WEILL CORNELL MEDICINE
19.28.1 BUSINESS OVERVIEW
20 REPORT SUMMARY
20.1 KEY TAKEAWAYS
20.2 STRATEGIC RECOMMENDATIONS
21 QUANTITATIVE SUMMARY
21.1 MARKET BY OWNERSHIP
21.2 MARKET BY APPLICATIONS
21.3 MARKET BY PAYOR
21.4 MARKET BY REGION
22 APPENDIX
22.1 ABBREVATIONS
EXHIBIT 1 SEGMENTATION OF US SLEEP DISORDER CLINICS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 US SLEEP DISORDER CLINICS MARKET: GROWTH RATE 2022–2027 (%)
EXHIBIT 4 IMPACT OF USE OF ADVANCED TECHNOLOGIES TO ADDRESS SLEEP-LOSS EPIDEMIC
EXHIBIT 5 IMPACT OF SHIFT TOWARD HOME-BASED CARE MODEL
EXHIBIT 6 IMPACT OF ADOPTION OF AI & CLOUD-BASED SOLUTIONS FOR SLEEP DISORDER MANAGEMENT
EXHIBIT 7 EMERGING SLEEP SENSING TECHNOLOGIES
EXHIBIT 8 IMPACT OF SURGE IN PREVALENCE OF SLEEP DISORDERS
EXHIBIT 9 IMPACT OF ECONOMIC BURDEN OF SLEEP DISORDERS
EXHIBIT 10 IMPACT OF RISE IN AWARENESS OF SLEEP DISORDERS
EXHIBIT 11 ADDRESSING FOLLOWING ISSUES IMPROVE ACCESS TO SLEEP CARE
EXHIBIT 12 IMPACT OF SHORTAGE OF PEDIATRIC SLEEP LABORATORIES
EXHIBIT 13 IMPACT OF COVID-19 & IMPLICATIONS ON SLEEP MEDICINE
EXHIBIT 14 IMPACT OF FRAUDULENT BILLING PRACTICES BY SLEEP STUDY CLINICS
EXHIBIT 15 US SLEEP DISORDER CLINICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 16 US SLEEP DISORDER CLINICS MARKET SHARE BY OWNERSHIP
EXHIBIT 17 US SLEEP DISORDER CLINICS MARKET SHARE BY APPLICATION
EXHIBIT 18 US SLEEP DISORDER CLINICS MARKET SHARE BY PAYOR
EXHIBIT 19 US SLEEP DISORDER CLINICS MARKET BY REGION
EXHIBIT 20 FIVE FORCES ANALYSIS 2021
EXHIBIT 21 INCREMENTAL GROWTH BY OWNERSHIP 2021 & 2027
EXHIBIT 22 US SLEEP DISORDER CLINICS MARKET BY OWNERSHIP: INCREMENTAL GROWTH
EXHIBIT 23 US SLEEP DISORDER CLINICS MARKET BY OWNERSHIP: ABSOLUTE GROWTH
EXHIBIT 24 PROS AND CONS OF AFFILIATED SLEEP CLINICS
EXHIBIT 25 US SLEEP DISORDER CLINICS MARKET BY AFFILIATED CLINICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 26 US SLEEP DISORDER CLINICS MARKET BY AFFILIATED CLINICS 2021–2027 ($ BILLION)
EXHIBIT 27 PROS AND CONS OF INDEPENDENT SLEEP CLINICS
EXHIBIT 28 US SLEEP DISORDER CLINICS MARKET BY INDEPENDENT CLINICS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 29 US SLEEP DISORDER CLINICS MARKET IN BY INDEPENDENT CLINICS 2021–2027 ($ BILLION)
EXHIBIT 30 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027
EXHIBIT 31 US SLEEP DISORDER CLINICS MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 32 US SLEEP DISORDER CLINICS MARKET BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 33 OTHER TESTS FOR SLEEP APNEA
EXHIBIT 34 US SLEEP DISORDER CLINICS MARKET BY SLEEP TESTING: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 35 US SLEEP DISORDER CLINICS MARKET BY SLEEP TESTING 2021–2027 ($ BILLION)
EXHIBIT 36 US SLEEP DISORDER CLINICS MARKET BY PAP THERAPY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 37 US SLEEP DISORDER CLINICS MARKET BY PAP THERAPY 2021–2027 ($ BILLION)
EXHIBIT 38 US SLEEP DISORDER CLINICS MARKET BY CONSULTATION: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 39 BENEFITS OF TELECONSULTATION
EXHIBIT 40 US SLEEP DISORDER CLINICS MARKET BY CONSULTATION 2021–2027 ($ BILLION)
EXHIBIT 41 US SLEEP DISORDER CLINICS MARKET BY OTHER APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 US SLEEP DISORDER CLINICS MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 43 INCREMENTAL GROWTH BY PAYOR 2021 & 2027
EXHIBIT 44 US HEALTH CONSUMPTION EXPENDITURES BY TYPE 2020 ($ BILLION)
EXHIBIT 45 US SLEEP DISORDER CLINICS MARKET BY PAYOR: INCREMENTAL GROWTH
EXHIBIT 46 US SLEEP DISORDER CLINICS MARKET BY PAYOR: ABSOLUTE GROWTH
EXHIBIT 47 US SLEEP DISORDER CLINICS MARKET BY PRIVATE HEALTH INSURANCE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 US SLEEP DISORDER CLINICS MARKET BY PRIVATE HEALTH INSURANCE 2021–2027 ($ BILLION)
EXHIBIT 49 US SLEEP DISORDER CLINICS MARKET BY PUBLIC HEALTH INSURANCE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 50 US SLEEP DISORDER CLINICS MARKET BY PUBLIC HEALTH INSURANCE 2021–2027 ($ BILLION)
EXHIBIT 51 US SLEEP DISORDER CLINICS MARKET BY OUT-OF-POCKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 US SLEEP DISORDER CLINICS MARKET BY OUT-OF-POCKET 2021–2027 ($ BILLION)
EXHIBIT 53 INCREMENTAL GROWTH BY REGION 2021 & 2027
EXHIBIT 54 US SLEEP DISORDER CLINICS MARKET BY REGION: INCREMENTAL GROWTH
EXHIBIT 55 US SLEEP DISORDER CLINICS MARKET BY REGION: ABSOLUTE GROWTH
EXHIBIT 56 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NEW YORK (%)
EXHIBIT 57 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN PENNSYLVANIA (%)
EXHIBIT 58 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NEW JERSEY (%)
EXHIBIT 59 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NEW HAMPSHIRE (%)
EXHIBIT 60 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN MASSACHUSETTS (%)
EXHIBIT 61 EAST US SLEEP DISORDER CLINICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 62 EAST US SLEEP DISORDER CLINICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 63 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN ALABAMA (%)
EXHIBIT 64 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN FLORIDA (%)
EXHIBIT 65 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN MISSISSIPPI (%)
EXHIBIT 66 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN TEXAS (%)
EXHIBIT 67 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN GEORGIA (%)
EXHIBIT 68 SOUTH US SLEEP DISORDER CLINICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 69 SOUTH US SLEEP DISORDER CLINICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 70 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN ARIZONA (%)
EXHIBIT 71 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NEVADA (%)
EXHIBIT 72 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN WASHINGTON (%)
EXHIBIT 73 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NEW MEXICO (%)
EXHIBIT 74 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN CALIFORNIA (%)
EXHIBIT 75 WEST US SLEEP DISORDER CLINICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 76 WEST US SLEEP DISORDER CLINICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 77 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN MISSOURI (%)
EXHIBIT 78 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN INDIANA (%)
EXHIBIT 79 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN ILLINOIS (%)
EXHIBIT 80 SLEEP DURATION AND CHRONIC CONDITIONS AMONG ADULTS IN NORTH DAKOTA (%)
EXHIBIT 81 MIDWEST US SLEEP DISORDER CLINICS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 82 MIDWEST US SLEEP DISORDER CLINICS MARKET 2021–2027 ($ BILLION)
EXHIBIT 83 VENDORS IN US SLEEP DISORDER CLINICS MARKET: MARKET DOMINANCE ANALYSIS
EXHIBIT 84 US SLEEP DISORDER CLINICS MARKET: CAPABILITIES & EXPERTISE ASSESSMENT
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 REQUIRED NUMBER OF AVERAGE SLEEPING HOURS (BY AGE)
TABLE 4 RISK OF CHRONIC HEALTH CONDITIONS DUE TO SLEEP DEPRIVATION
TABLE 5 SLEEP STUDIES COVERED BY MEDICARE
TABLE 6 PREVALENCE OF SHORT SLEEP DURATION IN NEW YORK (BY AGE)
TABLE 7 PREVALENCE OF SHORT SLEEP DURATION IN PENNSYLVANIA (BY AGE)
TABLE 8 PREVALENCE OF SHORT SLEEP DURATION IN NEW JERSEY (BY AGE)
TABLE 9 PREVALENCE OF SHORT SLEEP DURATION IN NEW HAMPSHIRE (BY AGE)
TABLE 10 PREVALENCE OF SHORT SLEEP DURATION IN MASSACHUSETTS (BY AGE)
TABLE 11 PREVALENCE OF SHORT SLEEP DURATION IN ALABAMA (BY AGE)
TABLE 12 PREVALENCE OF INADEQUATE SLEEP DURATION IN FLORIDA (BY AGE)
TABLE 13 PREVALENCE OF SHORT SLEEP DURATION IN MISSISSIPPI (BY AGE)
TABLE 14 PREVALENCE OF SHORT SLEEP DURATION IN TEXAS (BY AGE)
TABLE 15 PREVALENCE OF SHORT SLEEP DURATION IN GEORGIA (BY AGE)
TABLE 16 PREVALENCE OF SHORT SLEEP DURATION IN ARIZONA (BY AGE)
TABLE 17 PREVALENCE OF SHORT SLEEP DURATION IN NEVADA (BY AGE)
TABLE 18 PREVALENCE OF SHORT SLEEP DURATION IN WASHINGTON (BY AGE)
TABLE 19 PREVALENCE OF SHORT SLEEP DURATION IN NEW MEXICO (BY AGE)
TABLE 20 PREVALENCE OF SHORT SLEEP DURATION IN CALIFORNIA (BY AGE)
TABLE 21 PREVALENCE OF SHORT SLEEP DURATION IN MISSOURI (BY AGE)
TABLE 22 PREVALENCE OF SHORT SLEEP DURATION IN INDIANA (BY AGE)
TABLE 23 PREVALENCE OF SHORT SLEEP DURATION IN ILLINOIS (BY AGE)
TABLE 24 PREVALENCE OF SHORT SLEEP DURATION IN NORTH DAKOTA (BY AGE)
TABLE 25 US SLEEP DISORDER CLINICS MARKET BY OWNERSHIP 2021–2027 ($ BILLION)
TABLE 26 US SLEEP DISORDER CLINICS MARKET BY OWNERSHIP 2021–2027 ($ BILLION)
TABLE 27 US SLEEP DISORDER CLINICS MARKET BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 28 US SLEEP DISORDER CLINICS MARKET BY APPLICATIONS 2021–2027 (%)
TABLE 29 US SLEEP DISORDER CLINICS MARKET BY PAYOR 2021–2027 ($ BILLION)
TABLE 30 US SLEEP DISORDER CLINICS MARKET BY PAYOR 2021–2027 (%)
TABLE 31 US SLEEP DISORDER CLINICS MARKET BY REGION 2021–2027 ($ BILLION)
TABLE 32 US SLEEP DISORDER CLINICS MARKET BY REGION 2021–2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
